VOLORIDGE INVESTMENT MANAGEMENT, LLC

Position in EXEL — Exelixis, Inc.

CIK 1556921 JUPITER, FL

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,496,479

-$2,286,858 QoQ

Shares Held

578,873

-26.5% QoQ

Ownership

0.234%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#65

of 739 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $412,638,399 across 27 Biotechnology names. EXEL ranks #5 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	163,963	$102,237,489
2	IONS	Ionis Pharmaceuticals Inc	655,454	$51,970,947
3	RARE	Ultragenyx Pharmaceutical Inc.	1,241,556	$41,455,554
4	NTLA	Intellia Therapeutics, Inc.	2,066,356	$34,962,743
5	EXEL	Exelixis, Inc. This page	578,873	$31,496,479
6	BNTX	BioNTech SE	243,422	$22,650,417
7	ABSI	Absci Corp	1,602,916	$18,577,796
8	ARGX	Argenx SE	18,797	$17,439,292

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,496,479	578,873	-26.5%	Shares	Sole	2026-08-14
2026-03-31	$33,783,337	787,674	-18.0%	Shares	Sole	2026-05-15
2025-12-31	$42,110,461	960,768	+203.8%	Shares	Sole	2026-02-17
2025-09-30	$13,062,074	316,273	-20.7%	Shares	Sole	2025-11-14
2025-03-31	$14,717,604	398,635	-56.2%	Shares	Sole	2025-05-15
2024-12-31	$30,320,782	910,534	+116.8%	Shares	Sole	2025-02-14
2023-12-31	$10,074,912	419,963	+51.0%	Shares	Sole	2024-02-14
2023-09-30	$6,075,064	278,035	+734.4%	Shares	Sole	2023-11-14
2023-06-30	$636,802	33,323	-66.0%	Shares	Sole	2023-08-14
2023-03-31	$1,901,927	97,987	+828.8%	Shares	Sole	2023-05-15
2021-12-31	$192,854	10,550	-95.4%	Shares	Sole	2022-02-14
2021-09-30	$4,822,689	228,131	-31.0%	Shares	Sole	2021-11-15
2020-09-30	$8,084,759	330,665	+80.0%	Shares	Sole	2020-11-16
2020-06-30	$4,360,040	183,658	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.